Company Filing History:
Years Active: 2023
Title: Innovations by Hyun Joo Im in Pathogen Control
Introduction
Hyun Joo Im is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of methods and compositions for inhibiting the proliferation of pathogenic organisms. With a total of three patents to his name, his work is paving the way for advancements in medical treatments.
Latest Patents
Hyun Joo Im's latest patents focus on innovative compositions and methods for preventing or treating infections caused by pathogenic organisms. One of his patents involves a composition that includes a Podoviridae bacteriophage, known as Esc-COP-30, which has the ability to lyse pathogenic bacteria. This composition is designed to be used with a pharmaceutically acceptable carrier. Additionally, he has developed a method that involves administering this bacteriophage to a subject to effectively treat infections. Another significant patent features a Myoviridae bacteriophage, Esc-COP-18, which also targets pathogenic bacteria in a similar manner.
Career Highlights
Hyun Joo Im is currently associated with Intron Biotechnology, Inc., where he continues to innovate in the field of biotechnology. His work is crucial in developing new therapeutic strategies that leverage bacteriophages to combat bacterial infections.
Collaborations
Some of his notable coworkers include Seong Jun Yoon and Jee Soo Son, who contribute to the collaborative efforts in research and development at Intron Biotechnology, Inc.
Conclusion
Hyun Joo Im's contributions to biotechnology through his innovative patents are significant in the fight against pathogenic infections. His work exemplifies the potential of bacteriophage therapy in modern medicine.